# YEZTUGO
> **NDA220018** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2025-06-18
## Drug
- **FDA Application Number:** NDA220018
- **Application type:** New Drug Application
- **Brand name:** YEZTUGO
- **Generic name:** LENACAPAVIR SODIUM
- **Active ingredients:** LENACAPAVIR
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2025-06-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220018)
---
*AI Analytics · CC0 1.0*